On August 13, 2024, at Pier Mauá, Heptech made its mark at RIW 2024. The company showcased its latest advancements in enhanced heparins, presenting innovative projects that promise to revolutionize the treatment of thrombotic diseases. At the event, Heptech highlighted its research on new heparin formulations aimed at increasing efficacy and reducing side effects, contributing to safer and more effective medicine. Heptech’s participation in RIW 2024 not only reaffirmed its commitment to innovation but also emphasized the importance of partnerships with institutions like FAPERJ for advancing science and health.

See  the report on our participation in the event.